21 / 182
INDUSTRY GROUPS
“Influence policy development to create a
sustainable environment for the industry”
How do we create value
for the industry groups
To contribute towards an industry
viewpoint and response on regulatory
issues and health policy.
How do we engage with
the industry groups
Membership of and participation in:
Pharmaceuticals Made in South Africa
(PHARMISA); Self Medication Association
of South Africa (SMASA); and the
Pharmaceutical Task Group (PTG).
What are the associated risks
and opportunities for us and
the industry groups
The methodology used for single exit
pricing and other regulatory issues.
How do our operations
affect the industry
Participation supports the sustainability
and viability of the local pharmaceutical
industry.
FIVE
SIX
THREE
ONE
FOUR
TWO
CREATING VALUE FOR OUR STAKEHOLDERS
(continued)
| 17
Integrated Report 2016